- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Growth Stocks
U.S. Pharmaceuticals & Biotech High Growth Stocks
Results
4
High Growth Stocks
4 companies
Zevra Therapeutics
Market Cap: US$684.7m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.57
7D
2.0%
1Y
28.5%
Kiniksa Pharmaceuticals International
Market Cap: US$6.2b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$79.49
7D
1.7%
1Y
139.4%
Arcutis Biotherapeutics
Market Cap: US$3.2b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.54
7D
1.2%
1Y
68.3%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.51
7D
-3.1%
1Y
14.5%